These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24878183)

  • 21. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
    Gaillard PJ; Appeldoorn CC; Rip J; Dorland R; van der Pol SM; Kooij G; de Vries HE; Reijerkerk A
    J Control Release; 2012 Dec; 164(3):364-9. PubMed ID: 22732475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rediscovering the therapeutic use of glucocorticoids in rheumatoid arthritis.
    van der Goes MC; Jacobs JW; Bijlsma JW
    Curr Opin Rheumatol; 2016 May; 28(3):289-96. PubMed ID: 26962704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposomal encapsulation of glucocorticoids alters their mode of action in the treatment of experimental autoimmune encephalomyelitis.
    Schweingruber N; Haine A; Tiede K; Karabinskaya A; van den Brandt J; Wüst S; Metselaar JM; Gold R; Tuckermann JP; Reichardt HM; Lühder F
    J Immunol; 2011 Oct; 187(8):4310-8. PubMed ID: 21918186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New aspects of use inhaled steroids in treatment of children with bronchial asthma].
    Stelmach I; Jerzyńska J; Kuna P
    Pol Merkur Lekarski; 2000 May; 8(47):348-52. PubMed ID: 10944960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophages and liposomes in inflammatory disease: friends or foes?
    Crielaard BJ; Lammers T; Morgan ME; Chaabane L; Carboni S; Greco B; Zaratin P; Kraneveld AD; Storm G
    Int J Pharm; 2011 Sep; 416(2):499-506. PubMed ID: 21238559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal encapsulation of dexamethasone modulates cytotoxicity, inflammatory cytokine response, and migratory properties of primary human macrophages.
    Bartneck M; Peters FM; Warzecha KT; Bienert M; van Bloois L; Trautwein C; Lammers T; Tacke F
    Nanomedicine; 2014 Aug; 10(6):1209-20. PubMed ID: 24607939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel glucocorticoids: where are we now and where do we want to go?
    Buttgereit F; Spies CM; Bijlsma JW
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S29-33. PubMed ID: 26457359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of liposome as targeted magic bullet for inflammatory disorders: current state of the art.
    Rahman M; Kumar V; Beg S; Sharma G; Katare OP; Anwar F
    Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1597-608. PubMed ID: 26758815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inhaled glucocorticosteroids in treatment of bronchial asthma].
    Piotrowska B; Droszcz W
    Pol Merkur Lekarski; 1997 Feb; 2(8):126-8. PubMed ID: 9538658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dominance of the strongest: inflammatory cytokines versus glucocorticoids.
    Dejager L; Vandevyver S; Petta I; Libert C
    Cytokine Growth Factor Rev; 2014 Feb; 25(1):21-33. PubMed ID: 24412262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhaled corticotherapy in asthma: when should it be started and how to stop?].
    Aubier M
    Rev Pneumol Clin; 1996; 52(2):145-9. PubMed ID: 8761645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of new steroid preparations and their clinical applications].
    Mizushima Y
    Nihon Rinsho; 1984 Nov; 42(11):2503-8. PubMed ID: 6397615
    [No Abstract]   [Full Text] [Related]  

  • 34. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified release prednisone in patients with rheumatoid arthritis.
    Jacobs JW; Bijlsma JW
    Ann Rheum Dis; 2010 Jul; 69(7):1257-9. PubMed ID: 20525834
    [No Abstract]   [Full Text] [Related]  

  • 36. Delayed-release prednisone - a new approach to an old therapy.
    Buttgereit F; Gibofsky A
    Expert Opin Pharmacother; 2013 Jun; 14(8):1097-106. PubMed ID: 23594208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted inflammation could delay RA progress.
    Health News; 2006 Jul; 12(7):9. PubMed ID: 16862644
    [No Abstract]   [Full Text] [Related]  

  • 38. Nanomedicine delivers promising treatments for rheumatoid arthritis.
    Prasad LK; O'Mary H; Cui Z
    Nanomedicine (Lond); 2015; 10(13):2063-74. PubMed ID: 26084368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomes in the treatment of inflammatory disorders.
    Metselaar JM; Storm G
    Expert Opin Drug Deliv; 2005 May; 2(3):465-76. PubMed ID: 16296768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An overview of the adverse reactions to adrenal corticosteroids.
    Frauman AG
    Adverse Drug React Toxicol Rev; 1996 Nov; 15(4):203-6. PubMed ID: 9113247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.